Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Beck Peccoz

Showing results (191-200 of 201) with videos related to

Pageof 21
Sort By:
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
The clinical and molecular characterization of patients with dyshormonogenic congenital hypothyroidism reveals specific diagnostic clues for DUOX2 defectsM Muzza, S Rabbiosi, M C Vigone, et al.
Journal of Endocrinological Investigation|March 15, 2018
Analysis of characteristics and outcomes by growth hormone treatment duration in adult patients in the Italian cohort of the Hypopituitary Control and Complications Study (HypoCCS)V Rochira, G Mossetto, N Jia, et al.
Endocrine-Related Cancer|May 27, 2006
Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literatureL Fugazzola, E Puxeddu, N Avenia, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 29, 2011
Epicardial fat thickness significantly decreases after short-term growth hormone (GH) replacement therapy in adults with GH deficiencyE Ferrante, A E Malavazos, C Giavoli, et al.
European Journal of Endocrinology|November 13, 2013
Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patientsM Filopanti, A M Barbieri, G Mantovani, et al.
The Pharmacogenomics Journal|March 12, 2008
Dopamine D2 receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomasM Filopanti, A M Barbieri, A R Angioni, et al.
The EMBO Journal|August 26, 1998
A role for helix 3 of the TRbeta ligand-binding domain in coactivator recruitment identified by characterization of a third cluster of mutations in resistance to thyroid hormoneT N Collingwood, R Wagner, C H Matthews, et al.
The Journal of Clinical Endocrinology and Metabolism|December 12, 2001
Guidelines for diagnosis and therapy of MEN type 1 and type 2M L Brandi, R F Gagel, A Angeli, et al.
Journal of Endocrinological Investigation|November 8, 2014
Rare diseases in clinical endocrinology: a taxonomic classification systemG Marcucci, L Cianferotti, P Beck-Peccoz, et al.
European Journal of Endocrinology|May 19, 2012
Predictors of morbidity and mortality in acromegaly: an Italian surveyM Arosio, G Reimondo, E Malchiodi, et al.
Pageof 21

Showing results (191-200 of 201) with videos related to

Sort By:
Pageof 21
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
The clinical and molecular characterization of patients with dyshormonogenic congenital hypothyroidism reveals specific diagnostic clues for DUOX2 defectsM Muzza, S Rabbiosi, M C Vigone, et al.
Journal of Endocrinological Investigation|March 15, 2018
Analysis of characteristics and outcomes by growth hormone treatment duration in adult patients in the Italian cohort of the Hypopituitary Control and Complications Study (HypoCCS)V Rochira, G Mossetto, N Jia, et al.
Endocrine-Related Cancer|May 27, 2006
Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literatureL Fugazzola, E Puxeddu, N Avenia, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 29, 2011
Epicardial fat thickness significantly decreases after short-term growth hormone (GH) replacement therapy in adults with GH deficiencyE Ferrante, A E Malavazos, C Giavoli, et al.
European Journal of Endocrinology|November 13, 2013
Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patientsM Filopanti, A M Barbieri, G Mantovani, et al.
The Pharmacogenomics Journal|March 12, 2008
Dopamine D2 receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomasM Filopanti, A M Barbieri, A R Angioni, et al.
The EMBO Journal|August 26, 1998
A role for helix 3 of the TRbeta ligand-binding domain in coactivator recruitment identified by characterization of a third cluster of mutations in resistance to thyroid hormoneT N Collingwood, R Wagner, C H Matthews, et al.
The Journal of Clinical Endocrinology and Metabolism|December 12, 2001
Guidelines for diagnosis and therapy of MEN type 1 and type 2M L Brandi, R F Gagel, A Angeli, et al.
Journal of Endocrinological Investigation|November 8, 2014
Rare diseases in clinical endocrinology: a taxonomic classification systemG Marcucci, L Cianferotti, P Beck-Peccoz, et al.
European Journal of Endocrinology|May 19, 2012
Predictors of morbidity and mortality in acromegaly: an Italian surveyM Arosio, G Reimondo, E Malchiodi, et al.
Pageof 21